HCA Healthcare (HCA) Reiterated at Overweight by Cantor Fitzgerald on Stronger Q1 Data

Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $588.00 price target on HCA Healthcare Inc (NYSE: HCA).

The analyst commented, "1Q26 HCA data are stronger than that of peers in inpatient psych bonuses and physician bonuses. In psych, it was 1/3 providers to materially improve / decline opening, led by the % of psych openings with a bonus compression to 56.8% in 1Q26 vs. 69.6% in 4Q25. In physician, it was 1/4 providers to notably improve / lower physician openings with a bonus as it decreased 430bps to 75.6% in 1Q26 vs. 79.9% in 4Q25."

For an analyst ratings summary and ratings history on HCA Healthcare Inc click here. For more ratings news on HCA Healthcare Inc click here.

Shares of HCA Healthcare Inc closed at $483.92 yesterday.

You May Also Be Interested In

• Barclays Downgrades HCA Healthcare Inc (HCA) to Equalweight
• Commencement Bank Hires Vice President & SBA Lending Manager, Erin Shannon
• Day 7 ALJ Hearing: Prominent Pain Physician Calls State Medical Marijuana System a Ruse